Revenue Cycle Management: Market Overview

JULY 2026

U.S. Revenue Cycle Management Market Overview

The U.S. RCM market is expected to grow at an annual rate of 10.1% and reach $306.7 billion by 2030. Rapid market growth is fueled by rising automation, outsourcing, and increasing complexity across billing, coding, and payer rules.

Revenue Cycle Management Market Size

Segments / Descriptions

Elegibility & Patient Access. Verifies insurance coverage, benefits, and prior authorizations before care to reduce denials and ensure accurate financial responsibility upfront

Claims Management & Submission. Automates claim creation, scrubbing, coding validation, and electronic submission to payers, improving clean claim rates and speeding reimbursement

Denials Management and Appeals. Identifies denials, analyzes root causes, manages appeals workflows, and implements prevention strategies to recover revenue and reduce recurring rejections

Patient Billing & Collections. Manages patient invoicing, payment posting, collections, and payment plans to accelerate cash flow and improve patient financial experience

Commentary

  • Hospital-Led, Services-Heavy Market Structure: Hospitals remain the primary RCM end users due to scale and reimbursement complexity, while services account for over 68% of RCM revenue
  • Structural Complexity Sustains RCM Demand: Rising claim volumes, fragmented payer rules, and regulatory change continue to increase billing complexity, supporting ongoing adoption of advanced RCM solutions
  • Outsourcing and Tech Adoption Accelerating: 68% of providers outsource or have considered outsourcing RCM functions, driven by staffing shortages, cost pressure, and the need for accuracy
  • AI Expanding the RCM Value Proposition: AI-enabled, integrated platforms are automating denials, coding, and workflows; 82% of providers expect AI to have a positive impact on RCM over time
  • RCM Now a Strategic Priority: 88% of provider executives rank payer challenges among their top-three revenue cycle stressors, reflecting heightened focus on revenue integrity and upfront financial accuracy

Sources: AMB database, Publicly available information

Signals from Leading Operators

Leading operators signal convergence around AI automation, specialty services, complex claims recovery, and PE-led consolidation.

Insights from Market Leaders

1. AI-Driven RCM Automation
Vendors are embedding AI and RPA into billing and denial workflows to automate repetitive tasks, reduce errors, and accelerate processing, streamlining operations while driving measurable revenue gains

2. Specialty-Focused RCM Services
Operators are targeting niche verticals with tailored workflows and specialized coding expertise to drive greater accuracy, faster speed, and stronger collections

3. Complex Claims & Liability Recovery
Vendors that specialize in complex, non-standard claims are seeing premium demand thanks to their specialized workflows and deep expertise in handling these challenging cases

4. PE Consolidation
The sector's fragmentation fuels potential consolidation, especially in specialized areas like behavioral health and oncology, where tailored RCM solutions can close workflow gaps

Platform Examples

1. Al-Driven RCM Automation
2. Speciality-Focused RCM Services
3. Complex Claims & Liability Recovery
4. Consolidation

Sources: AMB database, Publicly available information

Key Factors Fueling Industry Demand

The combined impact of rising claims volume, complex payer rules, and persistent workforce shortages is heightening operational friction for health systems. This environment is driving sustained market demand for intelligent RCM tools capable of optimizing denials, collections, and revenue integrity.

Rising Healthcare Claims Volume
  • Growing patient utilization; outpatient visits (+6.3% YoY), inpatient admissions (+4.5% YoY), is expanding the number of claims hospitals must generate, submit, and manage
  • Electronic claim payments reached 510M transactions in 2024 (+4.6% YoY; +2,556% vs. 2013), reflecting a sustained surge in claim-processing workloads
  • U.S. outpatient volumes are projected to grow 10.6% over the next five years, further increasing transactional pressure on RCM systems and vendors
Higher Denial Rates & Increasing Insurance Complexity
  • Initial denial rates reached 11.5% in 2024, with increases in medicalnecessity and RFI denials, prompting providers to adopt more advanced denial-management and automation capabilities
  • Growing prior-authorization burden (physicians handle ~40 PAs/week, ~32% initially denied) and variable payer rules (ACA plans deny ~20% of claims) continue to add administrative complexity
  • Declining patient collections (-8.3% YoY) and rising accounts receivable days (+5.2% YoY) are driving demand for RCM platforms that improve revenue capture and accelerate cash flow
Financial & Operational Pressures
  • Hospitals continue to operate under tight margins (~4.9% in 2024) amid rising labor and non-labor costs, increasing the need for stronger revenue capture, denials prevention, and collections efficiency
  • Severe shortages in billing and coding staff, cited by ~90% of executives, are limiting throughput and pushing providers to adopt automation, AI-assisted coding, and outsourced RCM support
  • Rising out-of-pocket exposure, driven by HDHPs, high deductibles, and growing medical debt, requires more patient-facing RCM tools to improve collections and cash flow

Sources: AMB database, Publicly available information

U.S. Revenue Cycle Management Ecosystem

This ecosystem illustrates how healthcare end-users generate demand, how value is created across the revenue cycle workflow, and how solution providers deliver the technology and services that support it.

Solution Providers

Vendors delivering technology, outsourcing, and workflow solutions across the RCM lifecycle including front-end, mid-cycle, backend, and full end-to-end models

RCM Value Chain

The end-to-end administrative and financial workflow required to capture, manage, and collect patient revenue

Pre-service
Credentialing, payer contracting, scheduling, eligibility, authorization
Service
Provider delivers service; charge capture and coding
Billing
Claim generation, submission, denial management
Payment
Payer/patient payments, posting, collections
Post-payment
Reporting, KPI tracking, financial evaluation
Healthcare End-Users

Provider and payer organizations that generate demand for RCM support to manage billing, claims, and revenue across care settings

Sources: AMB database, Publicly available information

Tech and AI Adoption by Revenue Cycle Management Companies

AI adoption in RCM is rising as providers seek scalable tools to streamline coding, authorizations, and back-end revenue recovery, modernize manual workflows, and unlock faster, more predictable cash flow, driven by margin pressure and a push to reduce denials.

Why AI Adoption in RCM is Accelerating

  • RCM remains heavily manual, error-prone, and costly; hospitals lose $250B+ annually to administrative complexity and $262B to RCM inefficiencies
  • Providers face rising denials, workforce shortages, outdated data, and pressure to accelerate reimbursements
  • 46% of hospitals already use some form of AI in RCM, but adoption varies widely
  • Healthcare systems are gradually adopting AI-driven RCM, supported by strong leadership optimism, growing outsourcing, deeper payer analytics, and expanding AI/ML use, while balancing concerns around data, integration, and ROI

Measured Results from AI Adoption

AI-driven RCM (RPA, NLP, ML) cut Discharged, Not Final Billed (DNFB) by 50%, boosted coder productivity 40%, and raised Case Mix Index (CMI) by 4.6%

Automated coverage discovery and AI-generated denial appeals streamline workflows, using predictive models to guide write-offs

22% decrease in prior-auth denials, 18% fewer non-covered service denials, and 30–35 hours/week saved

Key Applications Across the RCM Cycle

Front-End Applications

  • Real-time eligibility verification using AIpowered data capture and payer databases
  • Automated detection of outdated or incorrect insurance data -> prevents denials at the start
  • AI-generated accurate out-of-pocket estimates improving collections and patient confidence

Mid-Cycle Applications

  • NLP-driven automated coding from clinical notes reduces human error and speeds claims
  • AI validates documentation, identifies missing data, and prevents coding inaccuracies
  • Automated prior authorization workflows; AI bots gather payer requirements and submit documents

Back-End Applications

  • AI claim scrubbing enables pre-submit detection of errors based on historical adjudication rules
  • Predictive denial analytics forecasting which claims will be denied and why
  • Automated appeal generation based on denial codes, policy manuals, and historical payer behavior

Source: Publicly available information

Regulatory Considerations

Evolving federal and state regulations are adding complexity to billing, compliance, and workflows across the revenue cycle.

Key Federal & National Regulations Shaping RCM

No Surprises Act (NSA): Establishes upfront cost estimates, bans surprise out-of-network billing, and mandates a dispute resolution process, raising documentation, estimation, and compliance requirements for providers and RCM vendors

Price Transparency Rules (Hospital & Payer)

Hospitals must publish negotiated rates; payers must offer real-time cost-sharing estimates. Requires accurate pricing data maintenance, tighter front-end workflows, and greater visibility

Interoperabiliy & Information Blocking (21st Century Cures Act)

Mandates open exchange of health information through APIs and prohibits data blocking and drives investment in data standards, eligibility integration, and interoperable RCM systems

Value-Based Care & Alternative Payment Model Frameworks

Expanding adoption of bundled payments, ACOs, and risk-based contracts requires RCM operators to track quality metrics, manage attribution, and reconcile shared savings/losses

HIPAA Security & Expanding State Privacy Laws

More stringent expectations for data protection, cybersecurity, and breach response, with states increasingly adding requirements beyond federal HIPAA standards

Structural Constraints & Barriers for RCM Operators

Margin pressure from declining Medicare rates, increasing uncompensated care, and Medicaid enrollment volatility (OBBBA work requirements, ACA subsidy risk)

Higher cost-to-collect due to more complex coding/documentation standards, greater audit exposure, and continuous compliance training needs

Required upfront investment in automation, AI, and secure infrastructure to meet evolving regulatory and payer expectations

Patient-centric rules such as income-based payment plans, charity care screening and dispute processes, are constraining traditional collections practices and increasing administrative load

State-Level Regulatory & Accreditation Dynamics

  • Credentialing timelines, documentation standards (e.g., Live Scan in CA, jurisprudence exams in TX), and telemedicine rules differ widely, slowing onboarding and expanding administrative workload
  • Most states exempt billing vendors, but New York enforces broad bans affecting Medicaid claims and, in some cases, commercial claims
  • State variations in data-handling and offshoring restrictions, impacting operating models (e.g., WI, TX, FL limit offshore handling of PHI or require data storage within the U.S./Canada, impacting vendor operating models)
  • States differ on medical-debt reporting bans, charity care requirements, payment-plan mandates, and disclosure obligations (e.g., MD income-based plans, FL price transparency)

Sources: AMB database, Publicly available information

Insights from the U.S. Revenue Cycle Management Market

Strategic Insights from Industry Veterans

Omry Bigger | President of Clinical Solutions, Elsevier | June 2026
"Clinicians today face a genuine tension: The patient data they need is in complex EHR systems, and the trusted evidence they need is somewhere else entirely. For health systems, this means governed AI at the point of care, built on verified content clinicians can trust and patient context they already have."

Doug Brown | Founder and President, Black Book Research | June 2026
"The next generation of hospital system RCM will be defined by payer intelligence, denial prevention, authorization readiness, front-end financial clearance, auditable AI, CFO-grade cash visibility and accountable managed operations working as one financial performance system."

Tony Morrison | VP & Chief Revenue Cycle Officer, Sanford Health | January 2026
"Automation is our top priority from a revenue cycle perspective in 2026. By reducing our reliance on manual processes, we can lower our cost to collect, improve accuracy and consistency and better support our revenue cycle teams."

Key Themes & Takeaways

  • RCM is shifting from reactive operations to proactive, AI-led control systems: Leaders are moving upstream, using AI, predictive analytics, and automation to prevent denials, documentation gaps, and underpayments before claims submission, rather than fixing issues post-denial
  • AI expectations have moved from experimentation to measurable ROI and transparency: The market is past pilots and “black-box” tools; buyers now demand explainable AI, clear financial impact (cash acceleration, denial reduction, cost-tocollect), and strong governance
  • Revenue cycle has become a C-suite priority amid regulation, margin pressure, and payer friction: Expanding audits, reimbursement pressure, and site-of-care shifts are elevating RCM from an operational function to a core strategic lever focused on revenue integrity and defense
  • RCM is becoming more integrated, clinically, operationally, and patient-facing: Clinical expertise is moving upstream into access and prior authorization, while interoperability and patient self-service tools are becoming essential to improve accuracy, transparency, and collections

Sources: AMB database, Publicly available information

Drug Development and R&D Advancements

After a pullback in 2024, deal volume has rebounded meaningfully, with sustained buyer interest in companies leveraging AI and technology-enabled solutions and/or companies offering acceptable AI investment requirements to enhance RCM.

Historical RCM M&A Volume

Investment Tailwinds & Headwinds

Value-Based Transition
The shift from fee-for-service to valuebased care is driving demand for more advanced RCM systems to manage bundled payments and quality metrics

Automation & AI Adoption
Growing use of AI, RPA, and cloud tools is streamlining billing, coding, and denial management, improving speed and accuracy across the revenue cycle

Increased Outsourcing
Health systems are increasingly outsourcing RCM to reduce costs, boost cash flow, and improve efficiency amid rising regulatory and financial pressure

High Implementation Costs
Upfront investment in RCM systems, including software, training, and IT support, can be cost-prohibitive, especially for smaller providers

Data Security Risks
RCM platforms manage sensitive patient data, creating ongoing cybersecurity and HIPAA compliance risks for healthcare organizations

Regulatory Complexity
Frequent payer policy changes and shifting regulations complicate claims processes, increasing denial rates and compliance burdens

Sources: AMB database, Publicly available information

Select M&A Activity

Value-Add Capabilities for SMOs

Date Seller Buyer Description
Jun-26 CanAide Med-Metrix Intelligent automation and revenue cycle platform for hospitals and health systems; combines RPA, AI-driven denial prevention, and patient enrollment support
May-26 Knack RCM, EqualizeRCM Carlyle Revenue cycle outsourcing platform for hospitals and health systems; consolidated a PE-backed scale position in healthcare RCM services.
Apr-26 Jopari Solutions Office Ally Electronic billing and payment network for workers' comp and auto-injury claims; extended acquirer's specialty payments infrastructure across payer-provider channels.
Mar-26 Saisystems Health Serent Capital Business process outsourcing platform for physician billing and coding; strengthened acquirer's multi-specialty RCM services footprint.
Jan-26 HealthAxis Group HandsOn Global Management Core administrative processing and BPO platform for health plans; advanced acquirer's build-out in Medicare Advantage and Medicaid technology infrastructure.
Nov-25 MedEvolve Emergence Practice management and RCM analytics platform for medical groups; enhanced acquirer's workflow automation and revenue performance capabilities.
Sep-25 Precision Practice Management Vee Healthtek Specialty-focused medical billing platform for anesthesia and radiology groups; expanded acquirer's presence in hospital-based specialty RCM.
Aug-25 Knack Global Carlyle Group Healthcare and insurance BPO platform spanning RCM and claims processing; scaled acquirer's offshore-delivery outsourcing model.
Aug-25 Sage Clinical RCM YES HIM Consulting Clinical billing and coding services platform for physician practices; supported acquirer's regional RCM consolidation strategy.

Key Trends

M&A activity accelerated in 2024–2025, driven by investor demand for tech-enabled scale and defensible platforms, with large RCM players pursuing roll-ups and health systems divesting RCM assets to unlock capital
Investors are favoring B2B RCM over DTC healthcare IT due to recurring revenue, lower CAC, and provider margin pressure driving demand for enterprise-grade solutions
I and automation are now core differentiators in RCM, with buyers underwriting platforms on AI readiness and tech-enabled providers achieving premium valuations
Private equity dominates RCM deal activity, deploying buy-and-build strategies across fragmented and specialty RCM segments with complex reimbursement dynamics

Sources: Publicly available information

Select RCM PE Platforms

Value-Add Capabilities for SMOs

Company Backing Date Service Focus Locations Growth Strategy Recent Acquisitions
May-26 RCM consulting
Credentialing
Medical coding
USA (12)
India (6)
Philippines (1)
Leverage Carlyle capital to scale organically and via M&A, expanding specialty and geographic RCM capabilities N / A
Jan-26 Pediatric billing
Claims & denials management
USA (1) Defend pediatric-only focus as a moat against generalist RCM vendors N / A
Aug-25 Medical coding
Patient access and financial management
USA (2)
Mexico (1)
India (7)
Philippines (1)
Leverage AI-driven automation and global delivery centers to expand RCM services and grow with large health-system clients
Jun-25 Patient intake
Revenue integrity and collection
USA (6)
India (1)
Philippines (1)
Leverage growth capital to scale organically and via M&A, expanding RCM/BI capabilities
Apr-25 Modular RCM with AI agents and human operators
Clinical insights and revenue optimization
USA (2)
Global service centers (24)
AI integrations from mergers, modular RCM solutions, and scaling to $200B revenue management
Dec-24 Patient access
Remote monitoring
Mid-Revenue cycle
USA (4)
India (7)
Colombia (1)
Philippines (2)
Bolstering nearshore delivery and heavy tech investments to advance its strategic end-to-end solutions
Nov-24 Pre-registration
Financial counseling
Charge capture
Medical coding
Denials management
USA (13)
India
International (9)
Focus on expanding its business through market penetration, service diversification, AI innovation and strategic acquisitions
May-24 Patient access
Medical coding
A/R optimization
USA (4)
India (4)
Acquire AI/RCM assets while scaling agentic automation across patient access workflows

Sources: Publicly available information

Select Players - Clinical and RCM Solutions

EHR, EMR and Practice Management

End-to-End RCM Platforms

Care Management Enablement

Sources: AMB database, Publicly available information

Select Players - RCM Point Solutions

Care Management & Coordination / Enablement

Revenue Integrity, Denials & Payment

Patient Financing & Payments

Prior Authorization

Patient access & intake automation

Sources: AMB database, Publicly available information

Select Players - Specialty-Specific Solutions

Post-Acute Care & Skilled Nursing

Behavioral

Dental

Medical Nutrition Therapy (MNT) / Nutrition

Women's and Maternal Health

Radiology / Imaging

Laboratory / Pathology

Sources: AMB database, Publicly available information

Important Disclosures

Allen Mooney & Barnes Brokerage Services is a broker/dealer member of FINRA and SIPC. Allen Mooney & Barnes Investment Advisors, Inc. is an investment adviser registered with the U.S. Securities and Exchange Commission.

Information presented in this document is for informational, educational and illustrative purposes only. While the information in this document is from sources believed to be reliable, the AMB companies make no representations or warranties, express or implied, as to whether the information is accurate or complete and assume no responsibility for independent verification of such information. In addition, the analyses in this document are narrowly focused and are not intended to provide a complete analysis of any matter.

Past performance is not necessarily indicative of future performance. Estimates, projections or indications of future performance can be identified by certain statements, such as "believes," "expects," "may," "will," "should," "seeks," "approximately," "plans," "estimates" or "anticipates" or the negative of those words or other comparable terminology, as well as by statements concerning projections, future performance, developments, events, revenues, expenses, earnings, run rates and any other guidance on present or future periods. Any such statements are forward-looking in nature and involve risks and uncertainties. Any statements of future performance are based on assumptions that might not be realized and a number of factors, including without limitation, the volatility of the securities markets, the overall environment for interest rates, risks associated with private equity investments, the demand for public offerings, activity in the secondary securities markets, competition among financial services firms for business and personnel, the effect of demand for public offerings, available technologies, the effect of government regulation and of general economic conditions on our own business and on the business in the industry areas on which we focus and the availability of capital to us. We are under no obligation to update the information presented in this document or to inform you if any such information turns out to be inaccurate or misleading.

The information in this document is not, and is not to be construed as, an offer or a solicitation to buy or sell any securities or any other financial instruments or a recommendation or endorsement to engage in or effect any particular investment or transaction. Moreover, under no circumstances should the information in this document be considered legal, tax or accounting advice or relied upon, therefore. The recipient is advised to rely on the advice of its own professionals and advisors for such matters and should make an independent analysis and decision regarding any transaction based upon such advice.

The information in this document is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or for any distribution or use that would subject the AMB companies to any registration requirement within such jurisdiction or country.

The information contained within this presentation is derived exclusively from publicly available resources that we believe to be reliable. No proprietary data, non-public information, or issuer-supplied materials were used in preparing this content.

677 King Street, Suite 410 | Charleston, SC 29403

AMB Investment Banking Snapshot and Deal Team

AMB focuses on lower middle-market healthcare niches where consumerism and fragmentation meet to disrupt traditional healthcare channels. We typically advise companies with EBITDA of $5M to $20M and an average enterprise value of $100M, but will move up and down the spectrum. AMB's research-oriented approach to business development has resulted in a vast network of strategic and financial sponsor relationships that yield industry leading intelligence and optimal outcomes for our clients.

Mikel Parker

Managing Director
843-501-2183 Direct
mikel.parker@ambadvisors.com

Ryan Loehr, CPA

Managing Director
843-405-1108 Direct
ryan.loehr@ambadvisors.com

Johnny Cross

Vice President
843-371-8596 Direct
johnny.cross@ambadvisors.com

Brayden Sarathy

Analyst
843-271-5652 Direct
brayden.sarathy@ambadvisors.com

Bella Worthington

Analyst
843-576-4711 Direct
bella.worthington@ambadvisors.com

Evan Migdole

Associate
860-510-2244 Direct
evan.migdole@ambadvisors.com